Second Sight Medical Products Company Profile (NASDAQ:EYES)

Analyst Ratings

Consensus Ratings for Second Sight Medical Products (NASDAQ:EYES) (?)
Ratings Breakdown: 2 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $18.50 (344.71% upside)

Analysts' Ratings History for Second Sight Medical Products (NASDAQ:EYES)
Show:
DateFirmActionRatingPrice TargetActions
7/26/2016Rodman & RenshawReiterated RatingBuy$16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/23/2016HC WainwrightReiterated RatingBuy$21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/26/2014 forward)

Earnings

Earnings History for Second Sight Medical Products (NASDAQ:EYES)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/28/2016Q216N/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/28/2016Q116($0.16)($0.13)$1.38 million$1.05 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/3/2016Q415($0.14)($0.13)$2.47 million$2.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2015Q315($0.14)($0.13)$2.05 million$2.23 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/4/2015Q215($0.14)($0.14)$1.73 million$2.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/13/2015Q115($0.12)$1.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/11/2015Q414($0.17)$1.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Second Sight Medical Products (NASDAQ:EYES)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Second Sight Medical Products (NASDAQ:EYES)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Second Sight Medical Products (NASDAQ:EYES)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/3/2016Edward David RandolphVPSell5,104$4.01$20,467.04View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/2/2016Robert J GreenbergChairmanSell8,571$4.10$35,141.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/18/2016Robert J GreenbergChairmanSell8,223$5.27$43,335.21View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/7/2015Robert J. GreenbergChairmanSell17,969$5.30$95,235.70View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/4/2015Anne-Marie Juliette RipleyVPSell2,500$5.50$13,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/4/2015Anne-Marie Juliette RipleyVPSell4,371$15.00$65,565.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2015Robert J GreenbergCEOSell150,000$14.04$2,106,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/27/2015Anne-Marie Juliette RipleyVPSell45,629$13.04$595,002.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/23/2015Robert J GreenbergCEOSell100,000$13.28$1,328,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/19/2014Gregg WilliamsDirectorBuy111,111$9.00$999,999.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Second Sight Medical Products (NASDAQ:EYES)
DateHeadline
07/26/16 04:00 PMAnalysts Update on Stocks: Boston Scientific Corporation (NYSE:BSX) , Second Sight Medical Products, Inc. (NASDAQ ... - Street Updates
07/26/16 04:00 PMCan Shares Of Second Sight Medical Products, Inc. (NASDAQ:EYES) Hit $16? - Investor Newswire
07/26/16 04:00 PMAnalyst Review: Second Sight Medical Products, Inc. (NASDAQ:EYES) - News Oracle
07/26/16 05:32 AMCompany Update (NASDAQ:EYES): Second Sight Medical Products Inc Announces Positive Five-Year Data from ... - Smarter Analyst
07/24/16 08:28 AMAnalysts: Second Sight Medical Products, Inc. (NASDAQ:EYES) stock is worth $16 - Review Fortune
07/23/16 08:02 AMSecond Sight Medical Products Inc (NASDAQ:EYES)'s Company Shares Increased 8.82% After Low Volatility - Consumer Eagle
07/23/16 08:02 AMRodman & Renshaw Comments on Second Sight Medical Products Inc (EYES) Following Positive Five-Year Data for ... - Smarter Analyst
07/21/16 09:28 PMSecond Sight Medical Products : Announces Positive Five-Year Data from Argus II Retinal Prosthesis System
07/21/16 04:08 PMSecond Sight Medical (EYES) Reports Positive Five-Year Data for Argus II - StreetInsider.com
07/21/16 04:08 PMSecond Sight Medical Products Inc (NASDAQ:EYES) Stock Volatility Hits An Extreme High - CML News
07/21/16 03:06 PM4:06 pm Second Sight Medical Products announces five-year data from Argus II Retinal Prosthesis System -
07/21/16 03:05 PMSecond Sight Announces Positive Five-Year Data from Argus II Retinal Prosthesis System - [Business Wire] - Second Sight Medical Products, Inc. , the developer, manufacturer and marketer of implantable visual prosthetics that provide some useful vision to blind patients, today announced positive five-year outcomes associated with patients using the Argus® II Retinal Prosthesis System .
07/20/16 05:37 AMIs $16 Price Target Attainable For Second Sight Medical Products, Inc. (NASDAQ:EYES)? - Investor Newswire
07/16/16 07:21 AMShares Experiencing a Downtrend: Second Sight Medical Products, Inc. (NASDAQ:EYES) - TGP
07/15/16 05:50 AMSecond Sight Medical Products Inc Stock Price Declines Today - Consumer Eagle
07/13/16 04:16 PMShare Volatility Watch for: Second Sight Medical Products, Inc. (NASDAQ:EYES) - Engelwood Daily
07/13/16 05:56 AMSession Volatility Review for: Second Sight Medical Products, Inc. (NASDAQ:EYES) - Engelwood Daily
07/13/16 05:56 AMStrong Sell Calls For Second Sight Medical Products, Inc. (NASDAQ:EYES) At 0 - Investor Newswire
07/12/16 08:19 AMSecond Sight Medical Products, Inc. (EYES) Broker Price Targets For The Coming Week - Fiscal Standard
07/07/16 09:08 PMStock Moving Up in Trading: Second Sight Medical Products, Inc. (NASDAQ:EYES) - Telanagana Press
07/07/16 09:08 PMHeightened Volatility Check on: Second Sight Medical Products, Inc. (NASDAQ:EYES) - Engelwood Daily
07/07/16 09:08 PMFollowing Unusual Volume for: Second Sight Medical Products, Inc. (NASDAQ:EYES) - Engelwood Daily
07/07/16 03:57 PMBuzz Stocks: PepsiCo, Inc., BioMarin Pharmaceutical Inc., and Second Sight Medical Products Inc
07/07/16 03:00 PMSecond Sight Soars on News While Navios Maritime Looks to Steam Ahead -
07/07/16 05:46 AMIncreased Volatility Watch for: Second Sight Medical Products, Inc. (NASDAQ:EYES) - Engelwood Daily
07/07/16 05:46 AMSecond Sight Medical Products, Inc. (NASDAQ:EYES) Expected to Reach Highs Of $16 - Investor Newswire
07/07/16 05:46 AMSecond Sight Medical Products, Inc. (EYES) Current Analyst Ratings - Fiscal Standard
07/03/16 03:41 PMCompany Stock Lower on the Week Second Sight Medical Products, Inc. (NASDAQ:EYES) - Engelwood Daily
07/01/16 06:17 AMSecond Sight Medical Products IN (NASDAQ:EYES) Shorts Decreased by 7.67% After Short Covering - Engelwood Daily
06/29/16 05:53 AMStrong Sell Calls Recommendations For Second Sight Medical Products, Inc. (NASDAQ:EYES) At 0 - Investor Newswire
06/28/16 08:58 PMSecond Sight Medical Products Inc's Trend Down, Especially After Today's 52-Week Low Hit - Engelwood Daily
06/27/16 03:52 PMStock Touching a Recent Low: Second Sight Medical Products, Inc. (NASDAQ:EYES) - Press Telegraph
06/27/16 03:52 PMNext Weeks Broker Price Targets For Second Sight Medical Products, Inc. (EYES) - Fiscal Standard
06/24/16 10:46 AMNew Broker Ratings For Second Sight Medical Products, Inc. (EYES) - FTSE News
06/22/16 09:06 PMStrong Buy Calls Count For Second Sight Medical Products, Inc. (NASDAQ:EYES) At 1 - Investor Newswire
06/15/16 05:08 AMSECOND SIGHT MEDICAL PRODUCTS INC Files SEC form 8-K, Other Events -
06/14/16 03:52 PMSecond Sight Medical Products Inc. (NASDAQ: EYES) Didn't Expect This - Scibility Media
06/14/16 03:52 PMSecond Sight Medical Products Inc. (NASDAQ: EYES) Didn't Expect This - Scibility Media
06/13/16 03:45 PMEarnings Trend of the Stocks: Second Sight Medical Products, Inc. (NASDAQ:EYES), Adobe Systems Incorporated ... - Beacon Chronicle
06/13/16 06:37 AMMoving Stocks: Second Sight Medical Products, (NASDAQ:EYES), Wedbush initiated coverage on Fitbit (NYSE:FIT ... - KC Register
06/10/16 06:43 AMRecent Update on Price Movements: Second Sight Medical Products, Inc. (NASDAQ:EYES), Geron Corporation ... - Street Updates
06/09/16 10:03 PMSecond Sight Rises on Fox News Report
06/05/16 03:52 PMAfter Last Week What Do Analysts Think Of Second Sight Medical Products, Inc. (EYES) - Share Trading News
06/05/16 03:52 PMAfter Last Week What Do Analysts Think Of Second Sight Medical Products, Inc. (EYES) - Share Trading News
06/03/16 04:08 PMBuy, Sell Or Hold Rating For Second Sight Medical Products, Inc. (EYES)? - Share Trading News
06/02/16 06:46 AMSecond Sight Medical Products Inc Formed a Bullish Inverse H&S Chart Pattern, Could Be One of The Best Performers ... - HNN - Second Sight Medical Products Inc Formed a Bullish Inverse H&S Chart Pattern, Could Be One of The Best Performers ...HNNThe stock of Second Sight Medical Products Inc (EYES) formed H&SI with $9.36 price target or 131.00% above the current $4.05 share price. The 9 months Head & Shoulders Inverse reveals low risk for the $149.01M company. This trade was featured by ...and more »
06/02/16 05:08 AMSECOND SIGHT MEDICAL PRODUCTS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits -
06/01/16 04:09 PMSecond Sight Medical Products, Inc. Announces Completion of Oversubscribed Rights Offering - Business Wire (press release) - Second Sight Medical Products, Inc. Announces Completion of Oversubscribed Rights OfferingBusiness Wire (press release)SYLMAR, Calif.--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, today ...and more »
06/01/16 09:43 AMSecond Sight Medical Products, Inc. Announces Completion of Oversubscribed Rights Offering - [at noodls] - SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES) ('Second Sight' or 'the Company'), a developer, manufacturer and marketer of implantable visual prosthetics to provide ...
05/30/16 08:58 PMSecond Sight Medical Products, Inc. (EYES) Broker Price Targets For The Coming Week - Share Trading News - Second Sight Medical Products, Inc. (EYES) Broker Price Targets For The Coming WeekShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Second Sight Medical Products, Inc. (EYES). The latest reports which are currently in issue on Monday 30th of May state 0 analysts have a rating of “strong buy”, 0 ...Second Sight Medical Products, Inc. (NASDAQ:EYES) Quarterly EPS From Continuing Operations Stands At $-0.1617Enterprise Leaderall 2 news articles »

Social

About Second Sight Medical Products

Second Sight Medical Products logoSecond Sight Medical Products, Inc. is a medical device company that develops, manufactures and markets implantable visual prosthetics to restore some functional vision to blind patients. The Company's product, the Argus II System, treats outer retinal degenerations, such as retinitis pigmentosa (RP). The Argus II System provides an artificial form of vision that differs from the vision that normally sighted people have. The Argus II Retinal Prosthesis System consists of an implant, a small portable computer and a pair of glasses with a miniature video camera. The Argus II system received Conformite Europeenne (CE) Mark approval for marketing and sales in the European Union (EU), and approval by the United States Food and Drug Administration (FDA) for marketing and sales in the United State. The Company also markets the Argus II system in Canada, Turkey, and at one medical center in Saudi Arabia.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: EYES
  • CUSIP:
Key Metrics:
  • Previous Close: $4.16
  • 50 Day Moving Average: $3.87
  • 200 Day Moving Average: $4.47
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $149.91M
  • Beta: 3.78
  • Current Year EPS Consensus Estimate: $-0.65 EPS
  • Next Year EPS Consensus Estimate: $-0.64 EPS
Additional Links:
Second Sight Medical Products (NASDAQ:EYES) Chart for Tuesday, July, 26, 2016